Given the known inverse associations of GH levels with VAT and hsCRP in obesity, [3, 24, 25] we expected to see a reduction in VAT content and in hsCRP levels following rhGH administration. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.